Eastman Chemical (NYSE: EMN) reported Q3 EPS of $2.05, $0.04 worse than the analyst estimate of $2.09. Revenue for the quarter came in at $2.71 billion versus the consensus estimate of $2.6 billion.

GUIDANCE:

Eastman Chemical sees Q4 2022 EPS of $1.10-$1.40, versus the consensus of $1.82.

Eastman Chemical sees FY2022 EPS of $8.05-$8.35, versus the consensus of $8.75.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.